|
|
Other links at Articles > HIV/AIDS |
| 2. |
HIV Patients Still at High Risk of Cancer
|
|
|
Although there has been a reduction in the incidence of some AIDS-defining cancers in people with HIV infection, there has been an increase in certain other cancers, researchers report in the July 1st issue of the International Journal of Cancer. Reuters Health Information
|
| 3. |
Genetic Disruption of CCR5 Renders T Cells HIV Resistant
|
|
|
The results of a mouse study provide proof of principle that a gene-editing approach using zinc finger nucleases can generate a population of HIV-resistant human T-cells similar to those in individuals who carry the natural CCR5-delta32 mutation. Reuters Health Information
|
| 5. |
Atazanavir Plus Lopinavir for HIV Effective in Men and Women
|
|
|
Results of the CASTLE study, a comparison of the HIV protease inhibitors atazanavir and ritonavir or lopinavir and ritonavir, "clearly favor" atazanavir, principal investigator Dr. Donnie McGrath announced at the International AIDS Conference (AIDS 2008) in Mexico City this week. Reuters Health Information
|
|
|